/Metlife%20Inc%20office-by%20Tupungato%20via%20Shutterstock.jpg)
New York-based MetLife, Inc. (MET) is a financial services company that provides insurance, annuities, employee benefits, and asset management services worldwide. Valued at $53 billion by market cap, the company also provides pension risk transfers, institutional income annuities, structured settlements, capital markets investment products, and other products and services. The global provider of insurance, annuities, and employee benefit programs is expected to announce its fiscal third-quarter earnings for 2025 after the market closes on Wednesday, Nov. 5.
Ahead of the event, analysts expect MET to report a profit of $2.30 per share on a diluted basis, up 19.2% from $1.93 per share in the year-ago quarter. The company missed the consensus estimates in each of the last four quarters.
For the full year, analysts expect MET to report EPS of $8.66, up 6.8% from $8.11 in fiscal 2024. Its EPS is expected to rise 16.5% year over year to $10.09 in fiscal 2026.
MET stock has underperformed the S&P 500 Index’s ($SPX) 13.4% gains over the past 52 weeks, with shares down 5.1% during this period. Similarly, it underperformed the Financial Select Sector SPDR Fund’s (XLF) 14.3% gains over the same time frame.
On Aug. 6, MET shares closed up more than 1% after reporting its Q2 results. Its adjusted EPS of $2.02 missed Wall Street expectations of $2.19. The company’s revenue stood at $17.3 billion, down 2.7% year over year.
Analysts’ consensus opinion on MET stock is reasonably bullish, with a “Moderate Buy” rating overall. Out of 19 analysts covering the stock, 12 advise a “Strong Buy” rating, one suggests a “Moderate Buy,” and six give a “Hold.” MET’s average analyst price target is $93.81, indicating a potential upside of 17.6% from the current levels.
